Display options
Cite
Kim JM, Park SJ, Sohn YM, et al. Development of clinical pharmacy services for intensive care units in Korea. Springerplus. 2014;3:34doi: 10.1186/2193-1801-3-34.
Kim, J. M., Park, S. J., Sohn, Y. M., Lee, Y. M., Yang, C. S., Gwak, H. S., & Lee, B. K. (2014). Development of clinical pharmacy services for intensive care units in Korea. SpringerPlus, 334. https://doi.org/10.1186/2193-1801-3-34
Kim, Jeong Mee, et al. "Development of clinical pharmacy services for intensive care units in Korea." SpringerPlus vol. 3 (2014): 34. doi: https://doi.org/10.1186/2193-1801-3-34
Kim JM, Park SJ, Sohn YM, Lee YM, Yang CS, Gwak HS, Lee BK. Development of clinical pharmacy services for intensive care units in Korea. Springerplus. 2014 Jan 17;3:34. doi: 10.1186/2193-1801-3-34. eCollection 2014. PMID: 24478944; PMCID: PMC3901852.
Copy Download .nbib Format: NLM
Share it on

Springerplus. 2014 Jan 17;3:34. doi: 10.1186/2193-1801-3-34. eCollection 2014.

Development of clinical pharmacy services for intensive care units in Korea.

SpringerPlus

Jeong Mee Kim, So Jin Park, You Min Sohn, Young Mee Lee, Catherine Seonghee Yang, Hye Sun Gwak, Byung Koo Lee

Affiliations

  1. College of Pharmacy & Division of Life and Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea ; Department of Pharmacy, Samsung Medical Center, Seoul, Korea.
  2. Department of Pharmacy, Samsung Medical Center, Seoul, Korea.
  3. College of Pharmacy & Division of Life and Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea.

PMID: 24478944 PMCID: PMC3901852 DOI: 10.1186/2193-1801-3-34

Abstract

OBJECTIVE: To be utilized for the development of pharmacists' intervention service by determining factors which affect pharmacists' prescription interventions.

SETTING: Patients who were admitted to intensive care units (ICUs) in internal medicine departments in Korea.

METHODS: Data including age, gender, clinical departments, length of hospital stay, status of organ dysfunction, intervention status, frequently intervened drugs, and health care providers' questions were prospectively collected in ICUs in the department of internal medicine in a tertiary teaching hospital from January to December, 2012.

MAIN OUTCOME MEASURE: Primary outcome was factors which affect pharmacists' prescription interventions. Secondary outcomes included frequencies of the intervention, intervention acceptance rates, intervention issues, and frequently intervened drugs.

RESULTS: A total of 1,213 prescription interventions were made for 445 patients (33.1%) of the 1,344 patients that were analyzed. Length of hospital stay was significantly longer for the group that needed pharmacists' interventions (p < 0.001). Pharmacists' intervention requirements were significantly higher in patients with kidney dysfunction (p < 0.001). The percentage of intervention accepted was 96.8%, and interventions that were common were as follows (in order): clinical pharmacokinetic service, dosage or dosing interval changes, dosing time changes or dose changes, and total parenteral nutrition consultation. The five medications with the highest intervened frequency were (in order) vancomycin, famotidine, ranitidine, meropenem, and theophylline.

CONCLUSION: The need for pharmacists' prescription interventions was highest among patients with longer length of stay and patients with kidney dysfunction. Based on these findings, prescription intervention activities could be initiated with severely ill patients. The results could be utilized in countries which are planning to develop pharmacists' intervention service.

Keywords: Clinical pharmacist; Intensive care unit; Intervention

References

  1. Arch Intern Med. 2006 May 8;166(9):955-64 - PubMed
  2. Am J Health Syst Pharm. 2009 Mar 1;66(5 Suppl 3):S29-34 - PubMed
  3. Crit Care Med. 1997 Aug;25(8):1289-97 - PubMed
  4. Intensive Care Med. 2001 Oct;27(10):1592-8 - PubMed
  5. Pharmacotherapy. 2000 Nov;20(11):1400-6 - PubMed
  6. Pharm World Sci. 2010 Feb;32(1):59-65 - PubMed
  7. JAMA. 1999 Jul 21;282(3):267-70 - PubMed
  8. Int J Clin Pharm. 2011 Apr;33(2):281-4 - PubMed
  9. Am J Health Syst Pharm. 2008 Jul 1;65(13):1254-60 - PubMed
  10. Intensive Care Med. 2003 May;29(5):691-8 - PubMed
  11. Pharm Pract (Granada). 2009 Apr;7(2):81-7 - PubMed
  12. Arch Intern Med. 2009 May 11;169(9):894-900 - PubMed
  13. Ann Pharmacother. 1992 Oct;26(10):1287-91 - PubMed
  14. Am J Health Syst Pharm. 2002 Nov 1;59(21):2089-92 - PubMed
  15. Am J Health Syst Pharm. 2007 Dec 1;64(23):2483-7 - PubMed
  16. Eur J Intern Med. 2013 Apr;24(3):227-33 - PubMed
  17. Ann Pharmacother. 1997 Jun;31(6):689-95 - PubMed

Publication Types